Showing results (351-360 of 5,003) with videos related to
Sort By:
Pageof 501
American Journal of Clinical Oncology|February 1, 1982
Adjuvant immunotherapy (BCG) in stage D prostate cancerP D Guinan, T John, G Baumgartner, et al.American Journal of Clinical Oncology|February 1, 1982
Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenograftsR D Clutterbuck, J L Millar, T J McElwainAmerican Journal of Clinical Oncology|December 1, 1982
Rubidazone in combination with Ara-C, vincristine and prednisone (ROAP) in the treatment of adult acute leukemia. A Southwest Oncology Group StudyF S Morrison, R Benjamin, M Amare, et al.American Journal of Clinical Oncology|October 1, 1982
A pilot study of mitomycin-C and tamoxifen (MT) versus dibromodulcitol, adriamycin, and tamoxifen (DAT)Y C Chang, G Falkson, D C Tormey, et al.American Journal of Clinical Oncology|October 1, 1982
A phase II study of aziridinylbenzoquinone (AZQ) in advanced large bowel carcinomaJ Rubin, G A van Hazel, A J Schutt, et al.American Journal of Clinical Oncology|August 1, 1982
AMSA and peptichemio in the treatment of advances metastatic breast cancer: a phase II studyA U Buzdar, S S Legha, G N Hortobagyi, et al.American Journal of Clinical Oncology|August 1, 1983
Phase II trial of 10-deaza-aminopterin in patients with advanced colorectal cancerE W Cheng, V E Currie, A YagodaAmerican Journal of Clinical Oncology|August 1, 1983
Chromosomes, cancer and radiosensitivityE SamouhosAmerican Journal of Clinical Oncology|June 1, 1982
Hydroxyurea versus busulfan in the treatment of chronic myelogenous leukemiaD Rushing, A Goldman, G Gibbs, et al.American Journal of Clinical Oncology|August 1, 1982
Phase II evaluation of dibromodulcitol, ICRF-159, and maytansine for sarcomasE C Borden, A Ash, H T Enterline, et al.Pageof 501